Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
21.57
-0.06 (-0.28%)
Aug 17, 2026, 3:29 PM EDT - Market open
Amylyx Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Amylyx Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $28.1. The average 1-year stock price forecast is 30.27% higher than the current stock price, while the lowest is $20 (-7.28%) and the highest is $40 (+85.44%).
Price Target: $28.1 (+30.27%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Amylyx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 10 | 10 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $24 → $30 | Buy | Reiterates | $24 → $30 | +39.08% | Aug 17, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $19 → $28 | Buy | Maintains | $19 → $28 | +29.81% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $34 | Buy | Maintains | $34 | +57.63% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $22 → $30 | Buy | Reiterates | $22 → $30 | +39.08% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
32.04M
EPS This Year
-1.47
from -1.53
EPS Next Year
-1.38
from -1.47
EPS and Forward PE are based on non-GAAP adjusted numbers.